ACutE POISOnInG WItH LIquID COnt AInInG GAmmA -ButyROLACt OnE (GBL)

Gamma-butyrolactone (GBL) is used as a solvent and cleaning agent, e.g. on chromium surfaces and to remove graffiti. After oral administration, it metabolises in the body to gamma-hydroxybutyric acid (GHB) and has a depressive effect (characteristic for this compound) on the central nervous system (CNS). This study presents a case of an acute, unintentional, oral poisoning of a 72 year old female with Pure Cleaner fluid, which contains GBL. The symptoms of poisoning developed rapidly. An unconscious, intubated woman with respiratory failure and bradycardia was admitted to the Toxicology Clinic in Krakow. Ingestion of sedative and hypnotic drugs and ethanol by the patient was ruled out by toxicological analysis. A diagnosis of poisoning was made on the basis of an interview and symptoms. Extensive toxicological analysis was performed with LC-MS. GBL was determined in the Pure Cleaner liquid that was brought to the Clinic together with the patient. The GHB concentration in the patient’s urine collected on admission to the hospital was 1550 mg/l (±201.5 mg/l).

[1]  S. Johansen,et al.  Simultaneous determination of γ-Hydroxybutyrate (GHB) and its analogues (GBL, 1.4-BD, GVL) in whole blood and urine by liquid chromatography coupled to tandem mass spectrometry. , 2011, Journal of analytical toxicology.

[2]  J. Ramsey,et al.  The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion , 2009, Journal of the Royal Society of Medicine.

[3]  W. Külpmann Clinical toxicological analysis : procedures, results, interpretation , 2009 .

[4]  H. Edwards,et al.  Identification of the date-rape drug GHB and its precursor GBL by Raman spectroscopy. , 2009, Drug Testing and Analysis.

[5]  P. Wax,et al.  Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review. , 2008, CJEM.

[6]  J. Dyer,et al.  Clinical Pharmacology of 1,4‐Butanediol and Gamma‐hydroxybutyrate After Oral 1,4‐Butanediol Administration to Healthy Volunteers , 2007, Clinical pharmacology and therapeutics.

[7]  R. Speich,et al.  Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. , 2006, Drug and alcohol dependence.

[8]  S. Elliott,et al.  The presence of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic and non-alcoholic beverages. , 2005, Forensic science international.

[9]  A. Poling,et al.  Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats , 2005, Psychopharmacology.

[10]  Jerzy Leszek,et al.  Kwas γ-hydroksymasłowy (GHB) jako środek psychoaktywny , 2005 .

[11]  F. Tagliaro,et al.  Determination of gamma-hydroxybutyric acid in biological fluids by using capillary electrophoresis with indirect detection. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  R. Palmer Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate. , 2004, Toxicological reviews.

[13]  Laurent Galichet,et al.  Clarke's analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material , 2004 .

[14]  W. Kerns,et al.  Gamma Hydroxybutyric Acid (GHB) Intoxication , 2002 .

[15]  K. Sneed,et al.  Treatment of a young adult taking gamma-butyrolactone (GBL) in a primary care clinic. , 2002, The Journal of the American Board of Family Practice.

[16]  S. Traub GAMMA HYDROXYBUTYRIC ACID (GHB) INTOXICATION Academic Emergency Medicine 2002;9:730-739. , 2002 .

[17]  K. Miotto,et al.  Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. , 2001, The American journal on addictions.

[18]  W. Lynn,et al.  Gamma butyrolactone (GBL) withdrawal syndromes. , 2001, Psychosomatics.

[19]  L. Quang,et al.  Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. , 2000, Pediatric emergency care.

[20]  Jim T. Hill Disposition of Toxic Drugs and Chemicals in Man. Volume 1: Centrally-Acting Drugs , 1981 .